Subthalamic nucleus stimulation and compulsive use of dopaminergic medication in Parkinson's disease. - Wikidata - awgldk - TriplyDB

Subthalamic nucleus stimulation and compulsive use of dopaminergic medication in Parkinson's disease.

Subthalamic nucleus stimulation and compulsive use of dopaminergic medication in Parkinson's disease.

http://www.wikidata.org/entity/Q48145567

about

Gambling disorder during dopamine replacement treatment in Parkinson's disease: a comprehensive review The human subthalamic nucleus encodes the subjective value of reward and the cost of effort during decision-making Should impulse control disorders and dopamine dysregulation syndrome be indications for deep brain stimulation and intestinal levodopa?The hidden sister of motor fluctuations in Parkinson's disease: A review on nonmotor fluctuations.Mechanisms of body weight fluctuations in Parkinson's disease.Treatment of cognitive, psychiatric, and affective disorders associated with Parkinson's disease.Maladaptive reward-learning and impulse control disorders in patients with Parkinson's disease: a clinical overview and pathophysiology update Weight Gain following Pallidal Deep Brain Stimulation: A PET Study.Target Selection Recommendations Based on Impact of Deep Brain Stimulation Surgeries on Nonmotor Symptoms of Parkinson's Disease Asymmetric right/left encoding of emotions in the human subthalamic nucleus.Management of impulse control disorders in Parkinson's disease: Controversies and future approaches Linking reward processing to behavioral output: motor and motivational integration in the primate subthalamic nucleus Deep brain stimulation for the treatment of addiction: basic and clinical studies and potential mechanisms of action Future of brain stimulation: new targets, new indications, new technology.Impulse control disorders in Parkinson's disease: an overview from neurobiology to treatment.Parkinson's disease, the subthalamic nucleus, inhibition, and impulsivity.Neuropsychiatric Issues in Parkinson's Disease.Current Topics in Deep Brain Stimulation for Parkinson Disease.Medical Management of Parkinson's Disease after Initiation of Deep Brain Stimulation.Current applications and limitations of surgical treatments for movement disorders.Deep Brain Stimulation Emergencies: How the New Technologies Could Modify the Current Scenario.Profile of Neuropsychiatric Symptoms in Parkinson's Disease: Surgical Candidates Compared to Controls.Impulse control behaviors and subthalamic deep brain stimulation in Parkinson disease.Targeting the subthalamic nucleus in a preclinical model of alcohol use disorder.A preoperative metabolic marker of parkinsonian apathy following subthalamic nucleus stimulation.Personality, dopamine, and Parkinson's disease: Insights from subthalamic stimulation.International validation of a behavioral scale in Parkinson's disease without dementia.Management of impulse control disorders in Parkinson's disease.Psychostimulant effect of dopaminergic treatment and addictions in Parkinson's disease.Impulse control behaviours in patients with Parkinson's disease after subthalamic deep brain stimulation: de novo cases and 3-year follow-up.Iowa gambling task impairment in Parkinson's disease can be normalised by reduction of dopaminergic medication after subthalamic stimulation.[Surgical strategy to rescue the addicts].Closed Loop Deep Brain Stimulation for PTSD, Addiction, and Disorders of Affective Facial Interpretation: Review and Discussion of Potential Biomarkers and Stimulation Paradigms.Impulsive and compulsive behaviors in Parkinson's disease

P2860

Q21284663-04B9B964-341A-4B3A-A663-56DAFE93B7E0 Q27303498-56DCD578-94C5-494C-9D76-A208B99F26F4 Q27687503-ACF382B4-D728-49DB-B637-B7B68EB4A8BD Q30248922-40667FA1-FCDB-4FE9-BE77-2B5BAEC8D4C0 Q33693961-C6330140-059C-4121-B62C-356766EDA674 Q34388686-7D614C25-B468-490E-B531-403882E42B10 Q34423280-34AEC083-0089-45E7-A54D-AD3F630192F3 Q35987080-CC0CFA17-9442-40E4-A439-5A278FE4106C Q36701655-C4CCAACF-D892-41CB-90C8-44F03633E798 Q37261589-B0CB7D41-A148-4A0B-B334-FD21EDC64C70 Q37361959-6B03B96F-D938-43DD-AA31-53232B89E58A Q37398133-FE9F3D78-5CF7-426A-8A37-D0E9F4D96DEF Q38125935-70C19719-4AAF-4BCB-A679-F7FBE90F8349 Q38152385-3BCCD22D-66AE-4526-8A3A-BB23F55CF302 Q38211499-0F7AE4F3-C689-4C53-9575-E06D4AAD0681 Q38258234-CFE50F82-B460-415F-B54E-282408F90421 Q38799051-D4BDD3B3-F369-4C38-918A-DDC32FA3411C Q38878821-1492F668-5F16-40D7-A70F-31C922CE50AA Q38964782-C4A96275-E0C7-4BB7-91B1-54321055A8B2 Q39104200-A338E562-F89C-4860-887D-922A449CB175 Q39301681-21F33C98-B9E2-4004-B844-DB14DD7B2FFA Q39988350-6A16B587-ECD7-4A6B-A56C-FF866FFA5F0F Q40530060-03C45383-96BC-4C53-9871-93CC3279D869 Q47349956-01F91691-CDD0-4C93-B97F-7AA2615675DC Q47664452-CCB0B394-2783-4996-9497-3F3862792A69 Q47847221-8D980BB8-646E-4111-8638-8876493D3ABB Q48088853-3D5D9B25-9CD2-4A0C-AEEF-EF5A798E166C Q48177158-0E247F41-7AA8-4C17-B7DE-CD9FEA76F224 Q48615659-9E995C9A-9EC5-4C93-A18C-F600C35D7C1E Q48666119-2B65F4CE-E9AD-4B47-9295-15E84B718A63 Q48769110-EE5B7D13-D6ED-4361-B18E-9B50198DA902 Q52307362-67E88C8B-5BC0-46E0-BA6E-E4A172DCF292 Q55073721-B386B32C-0F09-47D8-8AE4-DCFE3FFB8241 Q58492844-B91D794D-5C1D-419F-9F34-A74B5A82BFA9

P2860

Subthalamic nucleus stimulation and compulsive use of dopaminergic medication in Parkinson's disease.

http://www.wikidata.org/entity/Q48145567

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Subthalamic nucleus stimulatio ...... cation in Parkinson's disease.

@en

Subthalamic nucleus stimulatio ...... cation in Parkinson's disease.

@nl

type

label

Subthalamic nucleus stimulatio ...... cation in Parkinson's disease.

@en

Subthalamic nucleus stimulatio ...... cation in Parkinson's disease.

@nl

prefLabel

Subthalamic nucleus stimulatio ...... cation in Parkinson's disease.

@en

Subthalamic nucleus stimulatio ...... cation in Parkinson's disease.

@nl

P1433

Q48145567-E10FBAF3-11B0-4E4D-B0A0-25FAE9B16EA4

P1476

Q48145567-62F96E2F-EA75-456D-B7BF-EBFD43845D44

P2093

Q48145567-07DB1B2D-A2A0-4C38-846C-04DD4DDAD633

Q48145567-4D7185CA-F2E3-40AD-8C15-4CD66753AF73

Q48145567-683C41CE-119F-4574-AC44-3C94FD5B7AA6

Q48145567-A153E3D7-E3A8-48BD-8E51-576AB7D7F741

Q48145567-A521FAE0-A51D-4FD6-99E8-A319B4513CA2

Q48145567-D2C9455D-4528-49D0-91C5-D966950B6223

P2860

Q48145567-0374F7F7-FCF4-476D-9E6F-83192F971186

Q48145567-03E554B5-D437-43BC-8BED-C267D6658E8B

Q48145567-0776BD9F-B6C4-4DEE-AE3A-E1A2FC58338A

Q48145567-0DBF8B70-DA7E-4CD0-8DC5-42FF8A46997E

Q48145567-0DBFC9DA-7BEF-4227-979F-DC6F3731B648

Q48145567-163D743F-53C4-4024-9C71-2121AC880E5E

Q48145567-2B199169-364D-40C7-98E4-08C3F0FC2CF4

Q48145567-368D4137-D8CD-4A99-9FFC-F678B92D3695

Q48145567-4E3F4A37-0BFC-4485-B2EA-C4577412924D

Q48145567-4FCA29F0-544E-4F4E-8A0E-36808E721CA1

P304

Q48145567-91F87E3D-8CB9-453B-A4DA-A4D19C388871

P31

Q48145567-618BEC31-D860-43F3-88F0-3DCC6349A899

P356

Q48145567-C32A6F6E-44E2-432E-950A-86DF012DF3E6

P407

Q48145567-629871FB-5E3E-45F7-9C18-1B3E09A36295

P433

Q48145567-22C46F8F-BDC8-4FBD-B7F7-14CB44CF0F03

P478

Q48145567-D23DEDC5-7AE1-4056-A874-F60EFFAEDCED

P50

Q48145567-10725AE0-8785-4E29-85A2-ADE8AFF78D40

P577

Q48145567-69B08546-531A-4916-A0A2-F7163F7AB897

P698

Q48145567-F51A1C06-DC20-402B-A166-007CE899C1FE

P921

Q48145567-1081FA53-FDFF-45D2-8B98-18B200F7CA46

Q48145567-2368D63A-9433-4EEA-9F18-DBE0F110CCF2

Q48145567-970899D4-ECB7-4876-B5D8-7A72B0CDB3D0

P356

JNNP-2012-302387

P1433

Journal of Neurology, Neurosurgery and Psychiatry

P1476

Subthalamic nucleus stimulatio ...... cation in Parkinson's disease.

@en

P2093

Alexandre Eusebio

http://www.w3.org/2001/XMLSchema#string

Elisabeth Jouve

http://www.w3.org/2001/XMLSchema#string

Frédérique Fluchère

http://www.w3.org/2001/XMLSchema#string

Jean Régis

http://www.w3.org/2001/XMLSchema#string

Julien Cohen

http://www.w3.org/2001/XMLSchema#string

Tatiana Witjas

http://www.w3.org/2001/XMLSchema#string

P2860

Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies

Punding in Parkinson's disease: its relation to the dopamine dysregulation syndrome

Effects of STN and GPi deep brain stimulation on impulse control disorders and dopamine dysregulation syndrome

Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients.

Reducing the desire for cocaine with subthalamic nucleus deep brain stimulation.

Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT-PD).

Dopamine dysregulation syndrome: an overview of its epidemiology, mechanisms and management.

Behavioural disorders, Parkinson's disease and subthalamic stimulation.

Pathological gambling after bilateral subthalamic nucleus stimulation in Parkinson disease.

A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson's disease.

P304

868-874

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/JNNP-2012-302387

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

84

http://www.w3.org/2001/XMLSchema#string

P50

Jean-Philippe Azulay

P577

2013-02-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23447648

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

subthalamic nucleus